| Literature DB >> 28724742 |
Annalisa Natalicchio1, Nicola Marrano1, Giuseppina Biondi1, Rosaria Spagnuolo1, Rossella Labarbuta1, Immacolata Porreca2, Angelo Cignarelli1, Marco Bugliani3, Piero Marchetti3, Sebastio Perrini1, Luigi Laviola1, Francesco Giorgino4.
Abstract
This study explored the role of irisin as a new pancreatic β-cell secretagogue and survival factor and its potential role in the communication between skeletal muscle and pancreatic β-cells under lipotoxic conditions. Recombinant irisin stimulated insulin biosynthesis and glucose-stimulated insulin secretion (GSIS) in a PKA-dependent manner and prevented saturated fatty acid-induced apoptosis in human and rat pancreatic β-cells, as well as in human and murine pancreatic islets, via AKT/BCL2 signaling. Treatment of myotubes with 0.5 mmol/L palmitate for 4 h, but not with oleate, promoted an increase in irisin release in the culture medium. Moreover, increased serum levels of irisin were observed in mice fed with a high-fat diet. Mouse serum rich in irisin and the conditioned medium from myotubes exposed to palmitate for 4 h significantly reduced apoptosis of murine pancreatic islets and insulin-secreting INS-1E cells, respectively, and this was abrogated in the presence of an irisin-neutralizing antibody. Finally, in vivo administration of irisin improved GSIS and increased β-cell proliferation. In conclusion, irisin can promote β-cell survival and enhance GSIS and may thus participate in the communication between skeletal muscle and β-cells under conditions of excess saturated fatty acids.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28724742 DOI: 10.2337/db17-0002
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461